143 related articles for article (PubMed ID: 10068760)
21. No association between hOGG1, XRCC1, and XPD polymorphisms and risk of reflux esophagitis, Barrett's esophagus, or esophageal adenocarcinoma: results from the factors influencing the Barrett's adenocarcinoma relationship case-control study.
Ferguson HR; Wild CP; Anderson LA; Murphy SJ; Johnston BT; Murray LJ; Watson RG; McGuigan J; Reynolds JV; Hardie LJ
Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):736-9. PubMed ID: 18349297
[TBL] [Abstract][Full Text] [Related]
22. Pancreatic acinar metaplasia in Barrett's esophagus after antireflux surgery.
Marín Gabriel JC; Rodríguez Muñoz S; López Alonso G; García García E; Solís Herruzo JA
Rev Esp Enferm Dig; 2003 Dec; 95(12):890-3. PubMed ID: 14972009
[No Abstract] [Full Text] [Related]
23. The association of short segment Barrett's esophagus with intestinal metaplasia in stomach.
Tuncer I; Ugraş S; Uygan I; Türkdoğan K; Kösem M
Turk J Gastroenterol; 2003 Mar; 14(1):33-8. PubMed ID: 14593535
[TBL] [Abstract][Full Text] [Related]
24. Cyclooxygenase-2 and inducible nitric oxide synthase gene polymorphisms and risk of reflux esophagitis, Barrett's esophagus, and esophageal adenocarcinoma.
Ferguson HR; Wild CP; Anderson LA; Murphy SJ; Johnston BT; Murray LJ; Watson RG; McGuigan J; Reynolds JV; Hardie LJ
Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):727-31. PubMed ID: 18349295
[TBL] [Abstract][Full Text] [Related]
25. Pancreatic metaplasia in Barrett's esophagus. An immunohistochemical study.
Krishnamurthy S; Dayal Y
Am J Surg Pathol; 1995 Oct; 19(10):1172-80. PubMed ID: 7573675
[TBL] [Abstract][Full Text] [Related]
26. [Pathology of the cardia].
Takubo K; Mafune K; Tanaka Y; Sasajima K
Nihon Geka Gakkai Zasshi; 1998 Sep; 99(9):547-51. PubMed ID: 9842538
[TBL] [Abstract][Full Text] [Related]
27. The association between alcohol and reflux esophagitis, Barrett's esophagus, and esophageal adenocarcinoma.
Anderson LA; Cantwell MM; Watson RG; Johnston BT; Murphy SJ; Ferguson HR; McGuigan J; Comber H; Reynolds JV; Murray LJ
Gastroenterology; 2009 Mar; 136(3):799-805. PubMed ID: 19162028
[TBL] [Abstract][Full Text] [Related]
28. Recent advances in Barrett's esophagus: short-segment Barrett's esophagus and cardia intestinal metaplasia.
Sharma P
Semin Gastrointest Dis; 1999 Jul; 10(3):93-102. PubMed ID: 10435696
[TBL] [Abstract][Full Text] [Related]
29. Review article: management of oesophageal adenocarcinoma -- control of acid, bile and inflammation in intervention strategies for Barrett's oesophagus.
Jankowski JA; Anderson M
Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 5():71-80; discussion 95-6. PubMed ID: 15456468
[TBL] [Abstract][Full Text] [Related]
30. Barrett's esophagus: prevalence and its relationship with dyspeptic symptoms.
Toruner M; Soykan I; Ensari A; Kuzu I; Yurdaydin C; Ozden A
J Gastroenterol Hepatol; 2004 May; 19(5):535-40. PubMed ID: 15086597
[TBL] [Abstract][Full Text] [Related]
31. Barrett's esophagus: prevalence and size of hiatal hernia.
Cameron AJ
Am J Gastroenterol; 1999 Aug; 94(8):2054-9. PubMed ID: 10445527
[TBL] [Abstract][Full Text] [Related]
32. Surgical options and outcomes in Barrett's esophagus.
Zaninotto G; Rizzetto C
Curr Opin Gastroenterol; 2007 Jul; 23(4):452-5. PubMed ID: 17545785
[TBL] [Abstract][Full Text] [Related]
33. Gastrin induces proliferation in Barrett's metaplasia through activation of the CCK2 receptor.
Haigh CR; Attwood SE; Thompson DG; Jankowski JA; Kirton CM; Pritchard DM; Varro A; Dimaline R
Gastroenterology; 2003 Mar; 124(3):615-25. PubMed ID: 12612900
[TBL] [Abstract][Full Text] [Related]
34. Reduction of interleukin 8 gene expression in reflux esophagitis and Barrett's esophagus with antireflux surgery.
Oh DS; DeMeester SR; Vallbohmer D; Mori R; Kuramochi H; Hagen JA; Lipham J; Danenberg KD; Danenberg PV; Chandrasoma P; DeMeester TR
Arch Surg; 2007 Jun; 142(6):554-9; discussion 559-60. PubMed ID: 17576892
[TBL] [Abstract][Full Text] [Related]
35. [Histopathological diagnosis in reflux esophagitis].
Fujita M; Kusaka T; Hirabayashi K; Fujimori T
Nihon Rinsho; 2000 Sep; 58(9):1813-7. PubMed ID: 11004808
[TBL] [Abstract][Full Text] [Related]
36. The metabolic marker tumour pyruvate kinase type M2 (tumour M2-PK) shows increased expression along the metaplasia-dysplasia-adenocarcinoma sequence in Barrett's oesophagus.
Koss K; Harrison RF; Gregory J; Darnton SJ; Anderson MR; Jankowski JA
J Clin Pathol; 2004 Nov; 57(11):1156-9. PubMed ID: 15509675
[TBL] [Abstract][Full Text] [Related]
37. Association of Visceral Fat Area, Smoking, and Alcohol Consumption with Reflux Esophagitis and Barrett's Esophagus in Japan.
Matsuzaki J; Suzuki H; Kobayakawa M; Inadomi JM; Takayama M; Makino K; Iwao Y; Sugino Y; Kanai T
PLoS One; 2015; 10(7):e0133865. PubMed ID: 26225858
[TBL] [Abstract][Full Text] [Related]
38. Apoptosis and cell proliferation in the metaplasia-dysplasia-carcinoma-sequence of Barrett's esophagus.
Halm U; Tannapfel A; Breitung B; Breidert M; Wittekind CW; Mössner J
Hepatogastroenterology; 2000; 47(34):962-6. PubMed ID: 11020858
[TBL] [Abstract][Full Text] [Related]
39. Increased c-myb mRNA expression in Barrett's esophagus and Barrett's-associated adenocarcinoma.
Brabender J; Lord RV; Danenberg KD; Metzger R; Schneider PM; Park JM; Salonga D; Groshen S; Tsao-Wei DD; DeMeester TR; Hölscher AH; Danenberg PV
J Surg Res; 2001 Aug; 99(2):301-6. PubMed ID: 11469901
[TBL] [Abstract][Full Text] [Related]
40. REG Ialpha protein expression in Barrett's esophagus.
Chinuki D; Amano Y; Ishihara S; Moriyama N; Ishimura N; Kazumori H; Kadowaki Y; Takasawa S; Okamoto H; Kinoshita Y
J Gastroenterol Hepatol; 2008 Feb; 23(2):296-302. PubMed ID: 18289358
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
